Source: Aigenerated

Mirum Pharmaceuticals News: Upcoming investor conference appearances

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) said it will participate in several investor conferences in September 2026, with multiple fireside chats scheduled and webcast availability through the company’s investor relations website.

Mirum Pharmaceuticals News: Key Takeaways

  • Mirum will present at five investor conferences between Sept. 9 and Sept. 16, 2026.
  • Scheduled fireside chats include Cantor (Sept. 9, 10:55 a.m. ET), Citi’s (Sept. 10, 10:00 a.m. ET), H.C. Wainwright (Sept. 15, 9:00 a.m. ET) and Morgan Stanley (Sept. 16, 10:45 a.m. ET).
  • Mirum also listed attendance at the Baird 2026 Global Healthcare Conference on Sept. 15, 2026 (no webcast time was provided in the announcement).
  • The company said the fireside chats will be webcast live via the Investors section of its corporate website, with replays available afterward.

What happened?

Mirum announced its upcoming schedule of investor conference participation, including the dates and start times for several fireside chats. The company said investors can access the live webcasts and archived replays through the Investors section of Mirum’s corporate website.

Why this matters for investors

Conference appearances and webcasted fireside chats can provide incremental updates on company strategy, commercial performance, and pipeline priorities, even when no new financial or clinical data are released in the announcement. The schedule also indicates multiple opportunities in mid-September for management to address investor questions in a public forum.

The original press release is available on stockhouse.com

More From The Market Online
Meta Slips, SpaceX Pops Ahead of Earnings as Chips Fall

Market Open: Meta Slips Ahead of Earnings as Chips Lead Nasdaq Lower | Oct 20th

Meta slipped and SpaceX popped ahead of earnings as chip stocks dragged the Nasdaq down 1.18% and oil held near highs.

AI chip demand powers another strong quarter, demand elevated until 2030

ASML (NASDAQ:ASML) reported Q3 2026 net sales of €11.7 billion and net income of €5.0 billion, driven by demand for chipmaking equipment.

AI stock secures Medicaid coverage breakthrough

DataMeds AI (NASDAQ:MEDS) gained investor attention after Helomics secured Humana Medicaid coverage for the ChemoFx cancer assay.

Sekur Private Data to sponsor ASCIA law enforcement conference

Sekur Private Data said it will attend the ASCIA Fall Conference in Orlando as a silver sponsor on Oct. 22-24, 2026.